Citation only
via Europe PMC
Leukocytes and age-related macular degeneration.
Sandau N, Gorman BR, Luo J, Peachey NS, Nordestgaard BG, Tybjaerg-Hansen A, Thomassen JQ, Iyengar SK, Frikke-Schmidt R.
European journal of epidemiology · 2026
Abstract
Age-related macular degeneration (AMD) is a leading cause of vision loss. Leukocyte subtypes have been implicated in the pathogenesis, but causality remains uncertain. We investigated whether leukocyte counts are causally associated with clinically diagnosed AMD using observational and genetic analyses in three prospective cohorts. We included 117,714 individuals from the Copenhagen General Population Study (CGPS), 388,758 from the UK Biobank (UKB), and 285,612 from the Million Veteran Program (MVP), all of European ancestry and without clinically diagnosed AMD at baseline. In total, 27,130 incident AMD cases were identified. Baseline leukocyte counts were log2-transformed and standardized. Observational associations with incident AMD were estimated using Cox regression in CGPS and UKB, and then meta-analysed. Genetic instruments derived from genome-wide association studies were used for one-sample mendelian randomization (MR) and multivariable MR (MVMR) analyses in UKB and MVP, and estimates then meta-analysed. Observationally, a 1-standard deviation (SD) increase in leukocyte (Hazard ratio (HR) [95% confidence interval (CI)], 1.07 [1.05-1.09]), neutrophil (1.07 [1.05-1.09]), monocyte (1.05 [1.03-1.07]), basophil (1.06 [1.04-1.08]), and eosinophil (1.05 [1.03-1.06]) counts was associated with increased risk of clinically diagnosed AMD (all p < 0.0001). In the genetic analyses, a 1-SD increase in genetically determined eosinophil counts was causally associated with increased risk of clinically diagnosed AMD in the MR (OR [95% CI], 1.07 [1.00-1.15]; p = 0.038) and MVMR (OR [95% CI], 1.12 [1.03-1.21]; p = 0.006) analyses. This large-scale study provides observational and genetic evidence that elevated eosinophil counts are causally linked to risk of clinically diagnosed AMD. These findings highlight systemic eosinophil-driven immune pathways as potential contributors to AMD pathogenesis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s10654-026-01471-6
- Canonical
- link ↗
- Fetched
- 2026-10-22 MST
Cite this
APA
N, S., BR, G., J, L., NS, P., BG, N., A, T., JQ, T., SK, I., & R., F. (2026). Leukocytes and age-related macular degeneration. <em>European journal of epidemiology</em>. https://doi.org/10.1007/s10654-026-01471-6
Vancouver
N S, BR G, J L, NS P, BG N, A T, et al. Leukocytes and age-related macular degeneration. European journal of epidemiology. 2026. doi:10.1007/s10654-026-01471-6.
BibTeX
@article{sandau2026Leukoc,
title = {Leukocytes and age-related macular degeneration.},
author = {Sandau N and Gorman BR and Luo J and Peachey NS and Nordestgaard BG and Tybjaerg-Hansen A and Thomassen JQ and Iyengar SK and Frikke-Schmidt R.},
journal = {European journal of epidemiology},
year = {2026},
doi = {10.1007/s10654-026-01471-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2012
Preprint · OA
Genetic Studies of Age-related Macular Degeneration
Kocatepe University 2012
Open access · US-GOV
A Multicenter Study on the Investigation of Previously Verified Leading Gene Polymorphisms Related to Age-related Macular Degeneration in Turkish Population
Retina (Philadelphia, Pa.) 2026
Citation only
ASSOCIATION BETWEEN PREDIAGNOSTIC MACULAR THICKNESS WITH RISK OF AGE-RELATED MACULAR DEGENERATION.
Eye 2022
Open access · OA
Dyslipidemia in age-related macular degeneration
Injury 2026
Citation only
Age-related macular degeneration and secondary fracture risk in patients with hip fractures.
Science 2005
Citation only